Ignite Creation Date:
2024-05-05 @ 5:06 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00384436
Status:
COMPLETED
Last Update Posted:
2008-01-07
First Post:
2006-10-03
Brief Title:
Fixed Dose Comparison of Escitalopram to an Active Comparator in Severely Depressed Patients
Sponsor:
Forest Laboratories
Organization:
Forest Laboratories
Study Overview
Official Title:
Fixed Dose Comparison of Escitalopram to an Active Comparator in Severely Depressed Patients
Status:
COMPLETED
Status Verified Date:
2008-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the safety and efficacy of escitalopram to an active comparator in severely depressed patients
Detailed Description:
Escitalopram is the S-enantiomer of citalopram Both escitalopram and citalopram are selective serotonin reuptake inhibitors SSRIs and are used to treat depression in adults This study is designed to evaluate the safety and efficacy of escitalopram and an active comparator in severely depressed patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None